Marker Therapeutics
MRKR
32 hedge funds and large institutions have $3.09M invested in Marker Therapeutics in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 7 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 3
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
3% more funds holding
Funds holding: 31 → 32 (+1)
3.44% less ownership
Funds ownership: 30.14% → 26.71% (-3.4%)
41% less capital invested
Capital invested by funds: $5.22M → $3.09M (-$2.13M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
+$75.9K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$58.8K |
| 3 |
Renaissance Technologies
New York
|
+$45.4K |
| 4 |
Two Sigma Investments
New York
|
+$45.1K |
| 5 |
VF
Virtu Financial
New York
|
+$35K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$326K |
| 2 |
Jane Street
New York
|
-$33.4K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$24.3K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$19K |
| 5 |
LPL Financial
San Diego,
California
|
-$18.5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SS
26
SBI Securities
Tokyo,
Japan
| $181 | -$1.85K | -1,500 | -88% |
|
27
Group One Trading
Chicago,
Illinois
| $159 | – | – | – |
|
28
Fidelity Investments
Boston,
Massachusetts
| $134 | +$185 | +150 | New |
|
|
HNB
29
Hilltop National Bank
Casper,
Wyoming
| $65 | – | – | – |
|
30
JP Morgan Chase
New York
| $21 | -$237 | -192 | -89% |
|
31
BNP Paribas Financial Markets
Paris,
France
| $21 | – | – | – |
|
|
VCM
32
Versant Capital Management
Phoenix,
Arizona
| $13 | – | – | – |
|
|
33
Alyeska Investment Group
Chicago,
Illinois
| – | -$326K | -213,020 | Closed |
|
|
34
Jane Street
New York
| – | -$33.4K | -21,800 | Closed |
|
|
35
Dimensional Fund Advisors
Austin,
Texas
| – | -$24.3K | -15,900 | Closed |
|
|
36
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$19K | -12,437 | Closed |
|
37
Raymond James Financial
St Petersburg,
Florida
| – | -$14.6K | -9,515 | Closed |
|
|
TRCT
38
Tower Research Capital (TRC)
New York
| – | -$5.16K | -3,375 | Closed |
|
|
RAM
39
Riggs Asset Management
Dallas,
Pennsylvania
| – | -$1.84K | -1,200 | Closed |
|
MRKR Hedge Fund Activity: Q3 2025 in Review
32 of the 7,622 institutional investors tracked by Wall St. Rank reported a position in Marker Therapeutics (MRKR) for Q3 2025, worth a combined $3.09M — down 41% from $5.22M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new MRKR positions and 7 closed out — a net gain of 1 holder — while 9 added to existing stakes and 3 trimmed.
The largest buyer was Osaic Holdings, adding an estimated $75.9K. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $326K sold.
- 32 institutional investors held Marker Therapeutics (MRKR) as of Q3 2025, up from 31 in Q2 2025.
- Funds reported $3.09M of Marker Therapeutics stock for Q3 2025, down 41% quarter-over-quarter.
- 8 funds opened new Marker Therapeutics positions in Q3 2025 and 7 closed out, a net change of +1 holder.
- The largest Marker Therapeutics buyer in Q3 2025 was Osaic Holdings, an estimated $75.9K added.
- The largest Marker Therapeutics seller in Q3 2025 was Alyeska Investment Group, an estimated $326K sold.
Based on aggregated 13F filings for Q3 2025.